Cytomegalovirus Immune Globulin IV and Renal impairment
Result of checking the interaction of drug Cytomegalovirus Immune Globulin IV and disease Renal impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Immune Globulin Intravenous (human) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis and death. Patients predisposed to acute renal failure include patients with any degree of preexisting renal insufficiency, diabetes mellitus, age greater than 65, volume depletion, sepsis, paraproteinemia or patients receiving known nephrotoxic drugs. Especially in such patients, these products should be administered at the minimum concentrations available and the minimum rate of infusion practicable. Periodic monitoring of renal function tests and urine output is particularly important in patients judged to have a potential increased risk for developing acute renal failure. Renal function, including the measurement of blood urea nitrogen (BUN) and serum creatinine should be assessed prior to the initial infusion.
Generic Name: cytomegalovirus immune globulin
Brand Name: CytoGam
Synonyms: Cytomegalovirus immune globulin (CMV IG) (injection)